395873002: Sodium acid phosphate (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1469813019 Sodium acid phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489511017 Sodium acid phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1469813019 Sodium acid phosphate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1469813019 Sodium acid phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489511017 Sodium acid phosphate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1489511017 Sodium acid phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sodium acid phosphate	Is a	agent acidifiant	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sodium acid phosphate 1.72g suppository (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing methenamine mandelate and sodium phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Sodium acid phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing monobasic sodium phosphate and sodium bicarbonate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Sodium acid phosphate + sodium phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)
Sodium acid phosphate +sodium bicarbonate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sodium acid phosphate	Inferred relationship	Existential restriction modifier (core metadata concept)

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

SAME AS association reference set (foundation metadata concept)